HURA earnings: next report 2026-08-13, real EPS beat/miss history, analyst consensus Buy, P/E -3.65. Updated 2026-07-23.
TuHURA Biosciences (HURA) Research Hub
TuHURA Biosciences (HURA) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.05 USD (+1.99%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.65, market cap 0.14B. This hub links to the full technical, earnings and options research available for HURA.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.05 USD (+1.99%) |
| 52-week range | 1.99 USD – 2.72 USD |
| Trend regime | Range |
| 14-day RSI | 45.9 (Neutral) |
| Trailing P/E | -3.65 |
| Market cap | 0.14B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-13 |
Available research for HURA
Covered Call on HURA: how it works, illustrative setup around the real 2.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HURA: how it works, illustrative setup around the real 2.05 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HURA: how it works, illustrative setup around the real 2.05 USD price, max profit/loss, breakeven and when to use it. Educational.
HURA technical analysis: range, last 2.05 USD, RSI 45.9, 52w range 1.99 USD–2.72 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is HURA in?
TuHURA Biosciences (HURA) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is HURA in an uptrend or downtrend?
As of 2026-09-11, HURA is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HURA's trailing P/E ratio?
HURA's trailing P/E is -3.65, with a market cap of 0.14B. See the earnings research page for full valuation detail.
When does HURA next report earnings?
HURA is next scheduled to report earnings on 2026-08-13, with a consensus EPS estimate of -0.15333 USD.